Medications

FDA Approves Genentech’s Ocrevus (ocrelizumab) Shorter 2-Hour Infusion for Relapsing and Primary Progressive Multiple Sclerosis

South San Francisco, CA — December 14, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved a shorter two-hour infusion time for Ocrevus® (ocrelizumab), dosed twice-yearly for those living with relapsing or primary progressive multiple sclerosis (MS) who have […]

Health News

Rural Patients With Alzheimer Disease Have Shorter Survival

MONDAY, Oct. 26, 2020 — Rural Medicare beneficiaries with Alzheimer disease and related dementia (ADRD) spend more time in nursing homes, receive less home health care, and have shorter survival than their urban counterparts, according to a study published online Oct. 22 in JAMA Network Open. Momotazur Rahman, Ph.D., from the Brown University School of […]